Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB119252	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689134			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735941		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119252	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689144			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735951		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119253	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		44	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689154			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735961		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119253	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		44	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689164			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735971		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689174			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735981		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689184			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735991		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689194			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736001		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689204			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736011		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689183			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735990		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689193			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736000		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689202			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736009		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689203			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736010		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119258	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		45	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689214			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736021		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119258	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		45	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689224			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736031		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119259	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689234			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736041		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119259	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689244			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736051		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119260	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		23	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689254			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736061		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119260	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		23	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689264			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736071		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119261	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		40	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689274			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736081		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119261	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		40	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689284			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736091		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689128			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735935		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689138			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735945		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689148			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735955		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689158			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735965		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689168			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735975		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119263	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689178			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735985		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119263	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689179			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735986		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119263	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689188			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735995		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119263	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689189			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735996		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119263	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689198			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736005		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689208			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736015		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689218			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736025		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689228			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736035		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689238			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736045		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689248			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736055		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119265	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689180			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735987		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119265	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689181			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735988		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119265	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689190			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735997		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119265	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689199			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736006		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119265	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689200			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736007		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689209			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736016		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689219			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736026		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689229			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736036		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689239			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736046		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689249			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736056		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689129			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735936		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689139			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735946		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689149			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735956		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689159			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735966		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689169			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735976		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689130			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735937		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689140			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735947		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689150			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735957		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689160			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735967		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689170			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735977		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689210			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736017		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689220			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736027		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689230			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736037		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689240			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736047		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689250			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736057		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689182			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735989		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689191			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735998		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689192			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735999		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689201			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736008		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689263			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736070		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119271	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689258			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736065		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119271	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689259			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736066		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119271	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689268			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736075		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119271	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689269			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736076		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119271	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689278			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736085		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689260			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736067		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689261			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736068		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689270			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736077		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689279			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736086		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689280			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736087		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689211			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736018		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689221			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736028		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689231			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736038		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689241			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736048		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689251			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736058		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689131			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735938		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689141			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735948		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689151			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735958		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689161			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735968		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689171			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735978		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119275	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689262			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736069		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119275	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689271			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736078		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119275	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689272			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736079		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119275	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689281			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736088		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119275	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM778	Study group 2 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689282			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736089		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689212			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736019		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689222			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736029		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689232			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736039		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689242			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736049		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689252			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736059		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689132			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735939		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689142			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735949		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689152			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735959		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689162			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735969		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689172			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735979		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689133			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735940		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689143			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES735950		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689153			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735960		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689163			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735970		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689173			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735980		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689213			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736020		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689223			Protein		0.5	Days	Time of initial vaccine administration			PV2344	Day 0, Hour 12	EXP11771	ES736030		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689233			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736040		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689243			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736050		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689253			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736060		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689285			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736092		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689288			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736095		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689291			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736098		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689294			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736101		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689205			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736012		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689215			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736022		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689225			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736032		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689235			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736042		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119282	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689297			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736104		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119282	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689300			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736107		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119282	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689303			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736110		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119282	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689305			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736112		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119283	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689286			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736093		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119283	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689289			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736096		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119283	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689292			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736099		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119283	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689295			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736102		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689298			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736105		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689301			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736108		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689304			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736111		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689306			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736113		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689245			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736052		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689255			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736062		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689265			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736072		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689275			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736082		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689206			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736013		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689216			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736023		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689226			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736033		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689236			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736043		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689246			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736053		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689256			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736063		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689266			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736073		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689276			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736083		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119288	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689273			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736080		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119288	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689287			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736094		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119288	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689290			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736097		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119288	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		36	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689293			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736100		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689207			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736014		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689217			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736024		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689227			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736034		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689237			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736044		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689247			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736054		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689257			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736064		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689267			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736074		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689277			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736084		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689283			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736090		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388490	MBAA result	Plate2.388490.rbx	Plate2.rbx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689296			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES736103		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689299			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES736106		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689302			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES736109		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388491	MBAA result	Plate3.388491.rbx	Plate3.rbx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689125			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735932		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689135			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735942		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689145			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735952		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689155			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735962		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689165			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735972		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689175			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735982		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689185			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735992		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689195			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736002		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689126			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735933		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689136			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735943		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689146			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735953		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689156			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735963		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689166			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735973		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689176			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735983		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689186			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735993		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689196			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736003		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689127			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735934		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689137			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735944		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689147			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735954		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689157			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES735964		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689167			Protein		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11771	ES735974		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689177			Protein		1	Days	Time of initial vaccine administration			PV2346	Day 1	EXP11771	ES735984		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689187			Protein		3	Days	Time of initial vaccine administration			PV2349	Day 3	EXP11771	ES735994		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS689197			Protein		7	Days	Time of initial vaccine administration			PV2350	Day 7	EXP11771	ES736004		MBAA	None MBAA	ESR10102, ESR10103, ESR10104, ESR10105, ESR10106, ESR10107, ESR10108, ESR10109, ESR10110, ESR10111, ESR10112, ESR10113, ESR10114, ESR10115, ESR10116, ESR10117, ESR10118, ESR10119, ESR10120, ESR10121, ESR10122, ESR10123, ESR10124, ESR10125, ESR10126, ESR10127, ESR10128, ESR10129, ESR10130, ESR10131, ESR10132, ESR10133, ESR10134, ESR10135, ESR10136, ESR10137, ESR10138, ESR10139, ESR10140, ESR10141, ESR10142, ESR10143	EGF, EOTAXIN, FGF2, FLT3LIGAND, FRACTALKINE, GCSF, GMCSF, GRO, IFNA2, IFNG, IL1A, IL1B, IL1RA, IL2, IL3, IL4, IL5, IL6, IL7, IL8, IL9, IL10, IL12P40, IL12P70, IL13, IL15, IL17A, IP10, MCP1, MCP3, MDC, MIP1A, MIPB, PDGFAA, PDGFAB/BB, RANTES, SOLCD40L, sIL2RA, TGFA, TNFA, TNFB, VEGF		388488	MBAA result	Plate1.388488.rbx	Plate1.rbx
